RLYB
Rallybio Corp
16.80$
-2.6%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -5.40 | -7.93 | -11.34 | -14.40 | -11.92 | -9.05 | -5.30 | |
| 0.01 | 0.02 | 0.03 | 0.04 | 0.03 | 0.02 | 0.02 | |
| 0.07 | 0.25 | 0.91 | 2.39 | 2.16 | 1.47 | 0.94 | |
| 0.16 | 0.80 | 0.91 | 2.66 | – | – | – | |
| 0.74 | 0.76 | -0.94 | -0.24 | 0.85 | -0.05 | -0.74 | |
| 0.07 | 0.05 | 0.08 | 0.01 | 0.00 | 0.00 | 0.00 | |
| -0.07 | -0.75 | -0.58 | -28.20 | 5.47 | 6.15 | 8.40 | |
| – | – | 20.66 | 0.05 | 0.06 | 0.01 | 0.00 | |
| 11.35 | 52.11 | 20.66 | 12.84 | 0.03 | 0.96 | 0.00 | |
| 5.88 | 43.43 | 8.74 | -29.76 | -6.42 | -1.95 | 3.10 | |
| -5.47 | -7.98 | -11.42 | -14.41 | -11.92 | -9.05 | -5.30 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.